| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.987 | 0.001 | 0.987 | Androgen antagonist | 0.912 0.002 DBMET00372 0.98 0.001 DBMET02900 0.98 0.001 DBMET02901 0.959 0.002 DB14681 0.279 0.008 DBMET02905 0.354 0.005 DBMET02904 0.248 0.009 DBMET02906 0.289 0.008 DBMET02907 0.915 0.002 DBMET02902 0.789 0.002 DBMET02903 | ||
| 0.972 | 0.004 | 0.973 | Antiinflammatory | 0.969 0.004 DBMET00372 0.973 0.004 DBMET02900 0.973 0.004 DBMET02901 0.968 0.004 DB14681 0.967 0.004 DBMET02905 0.968 0.004 DBMET02904 0.96 0.004 DBMET02906 0.965 0.004 DBMET02907 0.967 0.004 DBMET02902 0.905 0.005 DBMET02903 | DBMET02901 | |
| 0.937 | 0.001 | 0.937 | Androgen agonist | 0.775 0.001 DBMET00372 0.91 0.001 DBMET02900 0.91 0.001 DBMET02901 0.862 0.001 DB14681 0.253 0.004 DBMET02905 0.331 0.003 DBMET02904 0.271 0.003 DBMET02906 0.316 0.003 DBMET02907 0.879 0.001 DBMET02902 0.855 0.001 DBMET02903 | ||
| 0.937 | 0.002 | 0.944 | Hypoxia-inducible factor 1 alpha inhibitor | 0.844 0.003 DBMET00372 0.846 0.003 DBMET02900 0.846 0.003 DBMET02901 0.884 0.002 DB14681 0.759 0.004 DBMET02905 0.944 0.002 DBMET02904 0.739 0.004 DBMET02906 0.84 0.003 DBMET02907 0.826 0.003 DBMET02902 0.751 0.004 DBMET02903 | DBMET02904 | |
| 0.922 | 0 | 0.922 | Transcortin receptor antagonist | 0.862 0 DBMET00372 0.902 0 DBMET02900 0.902 0 DBMET02901 0.875 0 DB14681 0.035 0.001 DBMET02905 0.036 0.001 DBMET02904 0.041 0.001 DBMET02906 0.048 0.001 DBMET02907 0.902 0 DBMET02902 0.332 0 DBMET02903 | ||
| 0.923 | 0.004 | 0.96 | Transcription factor NF kappa B inhibitor | 0.916 0.005 DBMET00372 0.919 0.005 DBMET02900 0.919 0.005 DBMET02901 0.9 0.006 DB14681 0.945 0.003 DBMET02905 0.96 0.003 DBMET02904 0.944 0.003 DBMET02906 0.96 0.003 DBMET02907 0.906 0.005 DBMET02902 0.799 0.013 DBMET02903 | DBMET02907 | |
| 0.863 | 0.002 | 0.863 | Antipruritic | 0.733 0.003 DBMET00372 0.78 0.003 DBMET02900 0.78 0.003 DBMET02901 0.787 0.003 DB14681 0.431 0.005 DBMET02905 0.603 0.004 DBMET02904 0.326 0.011 DBMET02906 0.443 0.005 DBMET02907 0.649 0.004 DBMET02902 0.44 0.005 DBMET02903 | ||
| 0.817 | 0.001 | 0.817 | Progesterone antagonist | 0.747 0.001 DBMET00372 0.721 0.001 DBMET02900 0.721 0.001 DBMET02901 0.632 0.002 DB14681 0.079 0.011 DBMET02905 0.157 0.006 DBMET02904 0.369 0.003 DBMET02902 0.347 0.003 DBMET02903 | ||
| 0.8 | 0.001 | 0.8 | Glucocorticoid antagonist | 0.67 0.001 DBMET00372 0.719 0.001 DBMET02900 0.719 0.001 DBMET02901 0.68 0.001 DB14681 0.326 0.002 DBMET02905 0.368 0.002 DBMET02904 0.234 0.003 DBMET02906 0.257 0.003 DBMET02907 0.48 0.002 DBMET02902 0.347 0.002 DBMET02903 | ||
| 0.794 | 0.002 | 0.862 | Aromatase inhibitor | 0.831 0.001 DBMET00372 0.685 0.002 DBMET02900 0.685 0.002 DBMET02901 0.862 0.001 DB14681 0.069 0.035 DBMET02905 0.132 0.016 DBMET02904 0.126 0.017 DBMET02906 0.158 0.012 DBMET02907 0.722 0.002 DBMET02902 0.6 0.003 DBMET02903 | DB14681 | |
| 0.79 | 0.005 | 0.79 | Toll-Like receptor 7 agonist | 0.768 0.005 DBMET00372 0.778 0.005 DBMET02900 0.778 0.005 DBMET02901 0.656 0.012 DB14681 0.591 0.018 DBMET02905 0.673 0.01 DBMET02904 0.37 0.072 DBMET02906 0.555 0.023 DBMET02907 0.675 0.01 DBMET02902 0.562 0.022 DBMET02903 | ||
| 0.785 | 0.005 | 0.785 | Toll-Like receptor agonist | 0.761 0.005 DBMET00372 0.772 0.005 DBMET02900 0.772 0.005 DBMET02901 0.651 0.012 DB14681 0.607 0.016 DBMET02905 0.678 0.01 DBMET02904 0.394 0.063 DBMET02906 0.563 0.022 DBMET02907 0.669 0.011 DBMET02902 0.567 0.021 DBMET02903 | ||
| 0.773 | 0.003 | 0.825 | Diuretic | 0.701 0.004 DBMET00372 0.714 0.004 DBMET02900 0.714 0.004 DBMET02901 0.626 0.004 DB14681 0.656 0.004 DBMET02905 0.825 0.003 DBMET02904 0.466 0.009 DBMET02906 0.614 0.005 DBMET02907 0.426 0.012 DBMET02902 0.649 0.004 DBMET02903 | DBMET02904 | |
| 0.782 | 0.019 | 0.842 | Apoptosis agonist | 0.758 0.022 DBMET00372 0.8 0.017 DBMET02900 0.8 0.017 DBMET02901 0.789 0.018 DB14681 0.826 0.014 DBMET02905 0.818 0.015 DBMET02904 0.833 0.013 DBMET02906 0.842 0.012 DBMET02907 0.836 0.012 DBMET02902 0.714 0.028 DBMET02903 | DBMET02907 | |
| 0.749 | 0.001 | 0.749 | Glucocorticoid agonist | 0.693 0.001 DBMET00372 0.737 0.001 DBMET02900 0.737 0.001 DBMET02901 0.684 0.001 DB14681 0.393 0.001 DBMET02905 0.467 0.001 DBMET02904 0.25 0.002 DBMET02906 0.314 0.002 DBMET02907 0.596 0.001 DBMET02902 0.25 0.002 DBMET02903 | ||
| 0.748 | 0.005 | 0.938 | Cholesterol antagonist | 0.691 0.009 DBMET00372 0.72 0.007 DBMET02900 0.72 0.007 DBMET02901 0.816 0.004 DB14681 0.902 0.002 DBMET02905 0.886 0.003 DBMET02904 0.936 0.002 DBMET02906 0.938 0.001 DBMET02907 0.879 0.003 DBMET02902 0.842 0.003 DBMET02903 | DBMET02907 | |
| 0.744 | 0.003 | 0.899 | Anesthetic general | 0.663 0.004 DBMET00372 0.796 0.003 DBMET02900 0.796 0.003 DBMET02901 0.841 0.002 DB14681 0.742 0.003 DBMET02905 0.659 0.004 DBMET02904 0.865 0.002 DBMET02906 0.883 0.002 DBMET02907 0.899 0.001 DBMET02902 0.786 0.003 DBMET02903 | DBMET02902 | |
| 0.744 | 0.004 | 0.746 | Immunosuppressant | 0.735 0.004 DBMET00372 0.746 0.004 DBMET02900 0.746 0.004 DBMET02901 0.71 0.005 DB14681 0.729 0.004 DBMET02905 0.73 0.004 DBMET02904 0.699 0.005 DBMET02906 0.7 0.005 DBMET02907 0.716 0.005 DBMET02902 0.714 0.005 DBMET02903 | DBMET02901 | |
| 0.739 | 0.001 | 0.739 | Aldosterone antagonist | 0.586 0.001 DBMET00372 0.461 0.002 DBMET02900 0.461 0.002 DBMET02901 0.526 0.002 DB14681 0.061 0.019 DBMET02905 0.151 0.005 DBMET02904 0.252 0.003 DBMET02902 0.356 0.003 DBMET02903 | ||
| 0.713 | 0.001 | 0.713 | Lipocortins synthesis antagonist | 0.687 0.001 DBMET00372 0.705 0.001 DBMET02900 0.705 0.001 DBMET02901 0.619 0.002 DB14681 0.622 0.002 DBMET02905 0.596 0.002 DBMET02904 0.524 0.003 DBMET02906 0.518 0.003 DBMET02907 0.598 0.002 DBMET02902 0.604 0.002 DBMET02903 | ||
| 0.72 | 0.022 | 0.795 | Caspase 9 stimulant | 0.715 0.022 DBMET00372 0.713 0.022 DBMET02900 0.713 0.022 DBMET02901 0.527 0.05 DB14681 0.787 0.013 DBMET02905 0.646 0.03 DBMET02904 0.745 0.018 DBMET02906 0.795 0.012 DBMET02907 0.744 0.019 DBMET02902 0.522 0.052 DBMET02903 | DBMET02907 | |
| 0.678 | 0.001 | 0.694 | Interferon gamma antagonist | 0.63 0.002 DBMET00372 0.636 0.002 DBMET02900 0.636 0.002 DBMET02901 0.658 0.001 DB14681 0.679 0.001 DBMET02905 0.686 0.001 DBMET02904 0.694 0.001 DBMET02906 0.694 0.001 DBMET02907 0.64 0.002 DBMET02902 0.603 0.002 DBMET02903 | DBMET02907 | |
| 0.658 | 0.012 | 0.662 | Aldehyde oxidase inhibitor | 0.551 0.026 DBMET00372 0.572 0.023 DBMET02900 0.572 0.023 DBMET02901 0.662 0.012 DB14681 0.636 0.014 DBMET02902 0.632 0.015 DBMET02903 | DB14681 | |
| 0.623 | 0.003 | 0.623 | Interleukin 8 antagonist | 0.32 0.004 DBMET00372 0.28 0.005 DBMET02900 0.28 0.005 DBMET02901 0.238 0.007 DB14681 0.196 0.014 DBMET02904 0.104 0.088 DBMET02902 0.137 0.043 DBMET02903 | ||
| 0.624 | 0.005 | 0.65 | P-glycoprotein inhibitor | 0.65 0.004 DBMET00372 0.632 0.004 DBMET02900 0.632 0.004 DBMET02901 0.594 0.005 DB14681 0.459 0.011 DBMET02905 0.512 0.008 DBMET02904 0.413 0.015 DBMET02906 0.492 0.009 DBMET02907 0.603 0.005 DBMET02902 0.326 0.024 DBMET02903 | DBMET00372 | |
| 0.559 | 0.004 | 0.559 | NOS3 expression enhancer | 0.457 0.006 DBMET00372 0.345 0.012 DBMET02900 0.345 0.012 DBMET02901 0.522 0.005 DB14681 0.413 0.007 DBMET02905 0.478 0.005 DBMET02904 0.383 0.009 DBMET02906 0.373 0.009 DBMET02907 0.348 0.012 DBMET02902 0.334 0.013 DBMET02903 | ||
| 0.528 | 0.003 | 0.528 | Estrogen receptor alpha antagonist | 0.412 0.004 DBMET00372 0.303 0.005 DBMET02900 0.303 0.005 DBMET02901 0.234 0.007 DB14681 0.131 0.015 DBMET02902 0.216 0.007 DBMET02903 | ||
| 0.519 | 0.004 | 0.573 | Interleukin 6 antagonist | 0.52 0.004 DBMET00372 0.573 0.004 DBMET02900 0.573 0.004 DBMET02901 0.434 0.006 DB14681 0.454 0.005 DBMET02905 0.48 0.005 DBMET02904 0.38 0.008 DBMET02906 0.492 0.005 DBMET02907 0.48 0.005 DBMET02902 0.224 0.029 DBMET02903 | DBMET02901 | |
| 0.512 | 0 | 0.512 | Arachidonic acid antagonist | 0.447 0 DBMET00372 0.474 0 DBMET02900 0.474 0 DBMET02901 0.463 0 DB14681 0.308 0.002 DBMET02905 0.328 0.001 DBMET02904 0.313 0.001 DBMET02906 0.331 0.001 DBMET02907 0.419 0 DBMET02902 0.36 0.001 DBMET02903 | ||
| 0.512 | 0.001 | 0.512 | Anabolic | 0.35 0.001 DBMET00372 0.453 0.001 DBMET02900 0.453 0.001 DBMET02901 0.373 0.001 DB14681 0.223 0.003 DBMET02905 0.213 0.003 DBMET02904 0.228 0.002 DBMET02906 0.211 0.003 DBMET02907 0.429 0.001 DBMET02902 0.485 0.001 DBMET02903 | ||
| 0.505 | 0.004 | 0.547 | Sodium/bile acid cotransporter inhibitor | 0.515 0.003 DBMET00372 0.547 0.003 DBMET02900 0.547 0.003 DBMET02901 0.469 0.005 DB14681 0.518 0.003 DBMET02905 0.446 0.008 DBMET02904 0.49 0.004 DBMET02906 0.482 0.005 DBMET02907 0.544 0.003 DBMET02902 0.47 0.005 DBMET02903 | DBMET02901 | |
| 0.493 | 0.004 | 0.493 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.426 0.006 DBMET00372 0.451 0.005 DBMET02900 0.451 0.005 DBMET02901 0.325 0.017 DB14681 0.277 0.031 DBMET02905 0.299 0.024 DBMET02904 0.166 0.115 DBMET02906 0.165 0.117 DBMET02907 0.288 0.027 DBMET02902 0.225 0.055 DBMET02903 | ||
| 0.496 | 0.014 | 0.592 | DNA synthesis inhibitor | 0.445 0.017 DBMET00372 0.492 0.014 DBMET02900 0.492 0.014 DBMET02901 0.373 0.026 DB14681 0.556 0.01 DBMET02905 0.592 0.008 DBMET02904 0.509 0.013 DBMET02906 0.573 0.009 DBMET02907 0.487 0.014 DBMET02902 0.292 0.046 DBMET02903 | DBMET02904 | |
| 0.484 | 0.017 | 0.75 | Nitric oxide antagonist | 0.537 0.013 DBMET00372 0.555 0.012 DBMET02900 0.555 0.012 DBMET02901 0.608 0.009 DB14681 0.653 0.007 DBMET02905 0.581 0.011 DBMET02904 0.75 0.005 DBMET02906 0.733 0.005 DBMET02907 0.701 0.006 DBMET02902 0.556 0.012 DBMET02903 | DBMET02906 | |
| 0.481 | 0.021 | 0.51 | Interleukin antagonist | 0.42 0.028 DBMET00372 0.51 0.019 DBMET02900 0.51 0.019 DBMET02901 0.343 0.04 DB14681 0.258 0.059 DBMET02905 0.36 0.037 DBMET02904 0.191 0.089 DBMET02907 0.28 0.052 DBMET02902 0.14 0.125 DBMET02903 | DBMET02901 | |
| 0.455 | 0.003 | 0.455 | Mineralocorticoid receptor antagonist | 0.377 0.003 DBMET00372 0.337 0.004 DBMET02900 0.337 0.004 DBMET02901 0.386 0.003 DB14681 0.081 0.011 DBMET02905 0.105 0.007 DBMET02904 0.054 0.025 DBMET02906 0.06 0.02 DBMET02907 0.139 0.005 DBMET02902 0.229 0.004 DBMET02903 | ||
| 0.43 | 0.002 | 0.436 | 5-Alpha-reductase inhibitor | 0.357 0.002 DBMET00372 0.415 0.002 DBMET02900 0.415 0.002 DBMET02901 0.436 0.002 DB14681 0.261 0.004 DBMET02905 0.262 0.004 DBMET02904 0.286 0.003 DBMET02906 0.282 0.003 DBMET02907 0.392 0.002 DBMET02902 0.429 0.002 DBMET02903 | DB14681 | |
| 0.432 | 0.004 | 0.432 | Estrogen antagonist | 0.373 0.005 DBMET00372 0.405 0.004 DBMET02900 0.405 0.004 DBMET02901 0.404 0.004 DB14681 0.197 0.013 DBMET02905 0.195 0.014 DBMET02904 0.17 0.018 DBMET02906 0.168 0.018 DBMET02907 0.313 0.005 DBMET02902 0.284 0.007 DBMET02903 | ||
| 0.413 | 0.007 | 0.582 | Alkylator | 0.403 0.007 DBMET00372 0.356 0.009 DBMET02900 0.356 0.009 DBMET02901 0.222 0.021 DB14681 0.582 0.004 DBMET02905 0.517 0.005 DBMET02904 0.443 0.006 DBMET02906 0.479 0.005 DBMET02907 0.326 0.011 DBMET02902 0.135 0.055 DBMET02903 | DBMET02905 | |
| 0.41 | 0.004 | 0.472 | Cholesterol synthesis inhibitor | 0.366 0.006 DBMET00372 0.416 0.004 DBMET02900 0.416 0.004 DBMET02901 0.38 0.005 DB14681 0.371 0.005 DBMET02905 0.371 0.006 DBMET02904 0.378 0.005 DBMET02906 0.372 0.005 DBMET02907 0.472 0.003 DBMET02902 0.459 0.003 DBMET02903 | DBMET02902 | |
| 0.435 | 0.03 | 0.591 | Apoptosis antagonist | 0.525 0.017 DBMET00372 0.424 0.032 DBMET02900 0.424 0.032 DBMET02901 0.396 0.04 DB14681 0.591 0.011 DBMET02905 0.555 0.014 DBMET02904 0.572 0.013 DBMET02906 0.584 0.011 DBMET02907 0.479 0.023 DBMET02902 0.403 0.037 DBMET02903 | DBMET02905 | |
| 0.401 | 0 | 0.401 | Corticosteroid-like | 0.306 0.001 DBMET00372 0.345 0.001 DBMET02900 0.345 0.001 DBMET02901 0.325 0.001 DB14681 0.179 0.001 DBMET02905 0.2 0.001 DBMET02904 0.142 0.001 DBMET02906 0.148 0.001 DBMET02907 0.243 0.001 DBMET02902 0.131 0.001 DBMET02903 | ||
| 0.438 | 0.04 | 0.693 | Immunostimulant | 0.387 0.054 DBMET00372 0.446 0.038 DBMET02900 0.446 0.038 DBMET02901 0.361 0.061 DB14681 0.652 0.012 DBMET02905 0.693 0.008 DBMET02904 0.621 0.014 DBMET02906 0.636 0.013 DBMET02907 0.439 0.039 DBMET02902 0.311 0.075 DBMET02903 | DBMET02904 | |
| 0.417 | 0.023 | 0.51 | Interleukin 2 agonist | 0.362 0.04 DBMET00372 0.333 0.054 DBMET02900 0.333 0.054 DBMET02901 0.402 0.027 DB14681 0.51 0.007 DBMET02905 0.46 0.014 DBMET02904 0.508 0.007 DBMET02906 0.415 0.023 DBMET02907 0.362 0.04 DBMET02902 0.432 0.019 DBMET02903 | DBMET02905 | |
| 0.391 | 0.012 | 0.391 | Melanin inhibitor | 0.24 0.03 DBMET00372 0.197 0.042 DBMET02900 0.197 0.042 DBMET02901 0.343 0.017 DB14681 0.185 0.048 DBMET02905 0.375 0.014 DBMET02904 0.2 0.041 DBMET02906 0.337 0.017 DBMET02907 0.192 0.044 DBMET02902 0.378 0.013 DBMET02903 | ||
| 0.379 | 0.004 | 0.409 | Estrogen agonist | 0.335 0.005 DBMET00372 0.365 0.004 DBMET02900 0.365 0.004 DBMET02901 0.409 0.004 DB14681 0.251 0.006 DBMET02905 0.236 0.007 DBMET02904 0.26 0.006 DBMET02906 0.249 0.006 DBMET02907 0.368 0.004 DBMET02902 0.388 0.004 DBMET02903 | DB14681 | |
| 0.396 | 0.036 | 0.616 | Antioxidant | 0.385 0.037 DBMET00372 0.389 0.037 DBMET02900 0.389 0.037 DBMET02901 0.38 0.039 DB14681 0.614 0.01 DBMET02905 0.585 0.012 DBMET02904 0.616 0.01 DBMET02906 0.615 0.01 DBMET02907 0.428 0.03 DBMET02902 0.501 0.02 DBMET02903 | DBMET02906 | |
| 0.39 | 0.031 | 0.44 | DNA damaging | 0.292 0.06 DBMET00372 0.377 0.034 DBMET02900 0.377 0.034 DBMET02901 0.287 0.062 DB14681 0.44 0.021 DBMET02905 0.388 0.031 DBMET02904 0.397 0.029 DBMET02906 0.339 0.044 DBMET02907 0.314 0.052 DBMET02902 | DBMET02905 | |
| 0.364 | 0.012 | 0.389 | Lipid peroxidase inhibitor | 0.302 0.019 DBMET00372 0.305 0.018 DBMET02900 0.305 0.018 DBMET02901 0.309 0.018 DB14681 0.371 0.011 DBMET02905 0.384 0.01 DBMET02904 0.322 0.016 DBMET02906 0.343 0.014 DBMET02907 0.247 0.027 DBMET02902 0.389 0.01 DBMET02903 | DBMET02903 | |
| 0.344 | 0.002 | 0.402 | RNA-directed RNA polymerase stimulant | 0.279 0.002 DBMET00372 0.402 0.001 DBMET02900 0.402 0.001 DBMET02901 0.345 0.002 DB14681 0.206 0.003 DBMET02905 0.173 0.003 DBMET02904 0.208 0.003 DBMET02906 0.185 0.003 DBMET02907 0.335 0.002 DBMET02902 0.33 0.002 DBMET02903 | DBMET02901 | |
| 0.38 | 0.05 | 0.459 | Caspase 3 stimulant | 0.446 0.031 DBMET00372 0.41 0.042 DBMET02900 0.41 0.042 DBMET02901 0.324 0.068 DB14681 0.418 0.039 DBMET02905 0.377 0.051 DBMET02904 0.409 0.042 DBMET02906 0.459 0.027 DBMET02907 0.449 0.03 DBMET02902 | DBMET02907 | |
| 0.406 | 0.087 | 0.761 | Cyclophilin D inhibitor | 0.346 0.125 DBMET00372 0.442 0.07 DBMET02900 0.442 0.07 DBMET02901 0.375 0.106 DB14681 0.761 0.009 DBMET02905 0.669 0.018 DBMET02904 0.759 0.009 DBMET02906 0.746 0.01 DBMET02907 0.536 0.041 DBMET02902 0.364 0.113 DBMET02903 | DBMET02905 | |
| 0.32 | 0.006 | 0.379 | Topoisomerase II alpha inhibitor | 0.288 0.008 DBMET00372 0.345 0.005 DBMET02900 0.345 0.005 DBMET02901 0.327 0.006 DB14681 0.188 0.017 DBMET02905 0.369 0.005 DBMET02904 0.199 0.015 DBMET02906 0.379 0.005 DBMET02907 0.314 0.006 DBMET02902 | DBMET02907 | |
| 0.313 | 0.002 | 0.336 | Progesterone agonist | 0.279 0.002 DBMET00372 0.264 0.002 DBMET02900 0.264 0.002 DBMET02901 0.336 0.001 DB14681 0.129 0.003 DBMET02905 0.149 0.003 DBMET02904 0.125 0.003 DBMET02906 0.127 0.003 DBMET02907 0.207 0.002 DBMET02902 0.219 0.002 DBMET02903 | DB14681 | |
| 0.328 | 0.023 | 0.619 | Hepatoprotectant | 0.346 0.02 DBMET00372 0.396 0.014 DBMET02900 0.396 0.014 DBMET02901 0.335 0.021 DB14681 0.6 0.005 DBMET02905 0.488 0.008 DBMET02904 0.619 0.004 DBMET02906 0.588 0.005 DBMET02907 0.456 0.009 DBMET02902 0.335 0.022 DBMET02903 | DBMET02906 | |
| 0.319 | 0.016 | 0.555 | Monophenol monooxygenase inhibitor | 0.227 0.027 DBMET00372 0.186 0.036 DBMET02900 0.186 0.036 DBMET02901 0.14 0.051 DB14681 0.4 0.011 DBMET02905 0.555 0.006 DBMET02904 0.206 0.032 DBMET02906 0.19 0.036 DBMET02907 0.19 0.036 DBMET02903 | DBMET02904 | |
| 0.335 | 0.037 | 0.747 | Angiogenesis stimulant | 0.312 0.045 DBMET00372 0.316 0.043 DBMET02900 0.316 0.043 DBMET02901 0.247 0.071 DB14681 0.747 0.004 DBMET02905 0.678 0.005 DBMET02904 0.684 0.005 DBMET02906 0.64 0.005 DBMET02907 0.301 0.049 DBMET02902 0.234 0.077 DBMET02903 | DBMET02905 | |
| 0.313 | 0.016 | 0.44 | Topoisomerase II inhibitor | 0.278 0.02 DBMET00372 0.321 0.016 DBMET02900 0.321 0.016 DBMET02901 0.332 0.015 DB14681 0.203 0.033 DBMET02905 0.392 0.01 DBMET02904 0.239 0.026 DBMET02906 0.44 0.008 DBMET02907 0.334 0.014 DBMET02902 | DBMET02907 | |
| 0.294 | 0.001 | 0.299 | Lipocortins synthesis agonist | 0.248 0.001 DBMET00372 0.299 0.001 DBMET02900 0.299 0.001 DBMET02901 0.215 0.001 DB14681 0.186 0.001 DBMET02905 0.201 0.001 DBMET02904 0.152 0.002 DBMET02906 0.167 0.001 DBMET02907 0.198 0.001 DBMET02902 0.148 0.002 DBMET02903 | DBMET02901 | |
| 0.326 | 0.045 | 0.49 | Tumour necrosis factor alpha release inhibitor | 0.289 0.058 DBMET00372 0.387 0.029 DBMET02900 0.387 0.029 DBMET02901 0.49 0.015 DBMET02905 0.475 0.016 DBMET02904 0.382 0.03 DBMET02906 0.421 0.024 DBMET02907 0.203 0.106 DBMET02902 0.213 0.098 DBMET02903 | DBMET02905 | |
| 0.367 | 0.093 | 0.688 | Antibacterial | 0.408 0.073 DBMET00372 0.46 0.053 DBMET02900 0.46 0.053 DBMET02901 0.318 0.122 DB14681 0.662 0.012 DBMET02905 0.67 0.011 DBMET02904 0.681 0.01 DBMET02906 0.688 0.01 DBMET02907 0.47 0.05 DBMET02902 0.383 0.085 DBMET02903 | DBMET02907 | |
| 0.271 | 0.004 | 0.271 | Estradiol 17 beta-dehydrogenase inhibitor | 0.171 0.005 DBMET00372 0.231 0.004 DBMET02900 0.231 0.004 DBMET02901 0.19 0.005 DB14681 0.153 0.006 DBMET02902 0.192 0.005 DBMET02903 | ||
| 0.273 | 0.009 | 0.304 | Farnesoid X receptor antagonist | 0.26 0.01 DBMET00372 0.293 0.006 DBMET02900 0.293 0.006 DBMET02901 0.238 0.013 DB14681 0.235 0.014 DBMET02905 0.159 0.044 DBMET02904 0.199 0.022 DBMET02906 0.188 0.025 DBMET02907 0.304 0.005 DBMET02902 0.224 0.016 DBMET02903 | DBMET02902 | |
| 0.266 | 0.004 | 0.266 | Estrogen receptor alpha agonist | 0.206 0.004 DBMET00372 0.234 0.004 DBMET02900 0.234 0.004 DBMET02901 0.257 0.004 DB14681 0.096 0.009 DBMET02905 0.095 0.009 DBMET02904 0.086 0.011 DBMET02906 0.076 0.013 DBMET02907 0.208 0.004 DBMET02902 0.249 0.004 DBMET02903 | ||
| 0.261 | 0.003 | 0.406 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.091 0.005 DBMET00372 0.146 0.004 DBMET02900 0.146 0.004 DBMET02901 0.381 0.003 DB14681 0.374 0.003 DBMET02902 0.406 0.003 DBMET02903 | DBMET02903 | |
| 0.267 | 0.014 | 0.298 | DNA intercalator | 0.227 0.019 DBMET00372 0.23 0.019 DBMET02900 0.23 0.019 DBMET02901 0.256 0.015 DB14681 0.108 0.066 DBMET02905 0.298 0.012 DBMET02904 0.105 0.069 DBMET02906 0.294 0.012 DBMET02907 0.232 0.019 DBMET02902 | DBMET02904 | |
| 0.277 | 0.026 | 0.44 | Neurotrophic factor enhancer | 0.27 0.028 DBMET00372 0.44 0.005 DBMET02900 0.44 0.005 DBMET02901 0.265 0.031 DB14681 0.317 0.014 DBMET02905 0.221 0.058 DBMET02904 0.319 0.014 DBMET02906 0.317 0.014 DBMET02907 0.41 0.005 DBMET02902 0.251 0.038 DBMET02903 | DBMET02901 | |
| 0.267 | 0.017 | 0.267 | Adenylate cyclase inhibitor | 0.151 0.044 DBMET00372 0.158 0.04 DBMET02900 0.158 0.04 DBMET02901 0.098 0.086 DB14681 0.131 0.059 DBMET02904 0.125 0.063 DBMET02903 | ||
| 0.252 | 0.007 | 0.252 | Estrogen receptor beta antagonist | 0.207 0.009 DBMET00372 0.231 0.008 DBMET02900 0.231 0.008 DBMET02901 0.245 0.007 DB14681 0.11 0.046 DBMET02905 0.105 0.056 DBMET02904 0.106 0.053 DBMET02906 0.099 0.067 DBMET02907 0.167 0.013 DBMET02902 0.191 0.01 DBMET02903 | ||
| 0.249 | 0.007 | 0.507 | AMP-activated protein kinase stimulant | 0.168 0.019 DBMET00372 0.138 0.036 DBMET02900 0.138 0.036 DBMET02901 0.427 0.004 DBMET02905 0.507 0.003 DBMET02904 0.163 0.021 DBMET02906 0.211 0.009 DBMET02907 0.097 0.075 DBMET02903 | DBMET02904 | |
| 0.242 | 0.003 | 0.291 | 5-Alpha-reductase 1 inhibitor | 0.12 0.004 DBMET00372 0.196 0.003 DBMET02900 0.196 0.003 DBMET02901 0.291 0.002 DB14681 0.146 0.004 DBMET02902 0.283 0.002 DBMET02903 | DB14681 | |
| 0.253 | 0.014 | 0.409 | Antineoplastic antibiotic | 0.279 0.011 DBMET00372 0.285 0.011 DBMET02900 0.285 0.011 DBMET02901 0.262 0.013 DB14681 0.282 0.011 DBMET02905 0.372 0.006 DBMET02904 0.315 0.009 DBMET02906 0.409 0.005 DBMET02907 0.333 0.008 DBMET02902 0.246 0.015 DBMET02903 | DBMET02907 | |
| 0.298 | 0.083 | 0.559 | Immunomodulator | 0.306 0.079 DBMET00372 0.234 0.128 DBMET02900 0.234 0.128 DBMET02901 0.213 0.149 DB14681 0.559 0.016 DBMET02905 0.526 0.019 DBMET02904 0.511 0.022 DBMET02906 0.415 0.04 DBMET02907 0.264 0.104 DBMET02902 | DBMET02905 | |
| 0.234 | 0.02 | 0.266 | DNA polymerase I inhibitor | 0.212 0.025 DBMET00372 0.215 0.024 DBMET02900 0.215 0.024 DBMET02901 0.216 0.024 DB14681 0.263 0.015 DBMET02905 0.213 0.024 DBMET02904 0.266 0.015 DBMET02906 0.223 0.022 DBMET02907 0.238 0.019 DBMET02902 0.217 0.023 DBMET02903 | DBMET02906 | |
| 0.208 | 0.003 | 0.278 | 5-Alpha-reductase 2 inhibitor | 0.107 0.005 DBMET00372 0.2 0.003 DBMET02900 0.2 0.003 DBMET02901 0.23 0.003 DB14681 0.017 0.016 DBMET02904 0.02 0.013 DBMET02906 0.018 0.015 DBMET02907 0.163 0.004 DBMET02902 0.278 0.002 DBMET02903 | DBMET02903 | |
| 0.203 | 0.005 | 0.203 | Estrogen receptor beta agonist | 0.165 0.006 DBMET00372 0.19 0.005 DBMET02900 0.19 0.005 DBMET02901 0.193 0.005 DB14681 0.116 0.01 DBMET02905 0.112 0.01 DBMET02904 0.103 0.011 DBMET02906 0.088 0.013 DBMET02907 0.151 0.007 DBMET02902 0.189 0.005 DBMET02903 | ||
| 0.198 | 0.003 | 0.203 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.18 0.003 DBMET00372 0.137 0.004 DBMET02900 0.137 0.004 DBMET02901 0.203 0.003 DB14681 0.057 0.007 DBMET02905 0.082 0.005 DBMET02904 0.075 0.005 DBMET02906 0.17 0.003 DBMET02907 0.183 0.003 DBMET02902 0.093 0.005 DBMET02903 | DB14681 | |
| 0.212 | 0.019 | 0.273 | Interleukin 4 antagonist | 0.16 0.041 DBMET00372 0.155 0.045 DBMET02900 0.155 0.045 DBMET02901 0.165 0.038 DB14681 0.168 0.036 DBMET02905 0.273 0.011 DBMET02904 0.148 0.051 DBMET02906 0.151 0.049 DBMET02907 0.166 0.037 DBMET02902 | DBMET02904 | |
| 0.184 | 0.003 | 0.319 | Na+ K+ transporting ATPase inhibitor | 0.17 0.004 DBMET00372 0.209 0.002 DBMET02900 0.209 0.002 DBMET02901 0.169 0.004 DB14681 0.213 0.002 DBMET02905 0.268 0.001 DBMET02904 0.22 0.002 DBMET02906 0.319 0.001 DBMET02907 0.214 0.002 DBMET02902 0.18 0.003 DBMET02903 | DBMET02907 | |
| 0.187 | 0.01 | 0.264 | Inducible nitric-oxide synthase inhibitor | 0.158 0.014 DBMET00372 0.127 0.022 DBMET02900 0.127 0.022 DBMET02901 0.264 0.005 DB14681 0.151 0.016 DBMET02902 0.091 0.046 DBMET02903 | DB14681 | |
| 0.177 | 0.002 | 0.787 | Glucose-6-phosphate dehydrogenase inhibitor | 0.176 0.002 DBMET00372 0.5 0.001 DBMET02900 0.5 0.001 DBMET02901 0.567 0.001 DB14681 0.117 0.003 DBMET02905 0.098 0.003 DBMET02904 0.164 0.002 DBMET02906 0.215 0.002 DBMET02907 0.787 0.001 DBMET02902 0.12 0.002 DBMET02903 | DBMET02902 | |
| 0.181 | 0.007 | 0.181 | Interleukin 5 antagonist | 0.144 0.013 DBMET00372 0.161 0.009 DBMET02900 0.161 0.009 DBMET02901 0.129 0.019 DB14681 0.095 0.048 DBMET02905 0.158 0.009 DBMET02904 0.109 0.033 DBMET02907 0.111 0.031 DBMET02902 0.078 0.077 DBMET02903 | ||
| 0.193 | 0.021 | 0.243 | Microtubule formation inhibitor | 0.184 0.024 DBMET00372 0.224 0.015 DBMET02900 0.224 0.015 DBMET02901 0.11 0.074 DB14681 0.243 0.01 DBMET02905 0.214 0.017 DBMET02904 0.2 0.02 DBMET02906 0.187 0.023 DBMET02907 0.174 0.027 DBMET02902 0.144 0.041 DBMET02903 | DBMET02905 | |
| 0.179 | 0.019 | 0.192 | Pregnane X receptor agonist | 0.177 0.021 DBMET00372 0.189 0.014 DBMET02900 0.189 0.014 DBMET02901 0.172 0.024 DB14681 0.185 0.016 DBMET02902 0.192 0.013 DBMET02903 | DBMET02903 | |
| 0.155 | 0.006 | 0.179 | Glycine receptor antagonist | 0.132 0.013 DBMET00372 0.143 0.009 DBMET02900 0.143 0.009 DBMET02901 0.116 0.02 DB14681 0.179 0.004 DBMET02905 0.163 0.005 DBMET02904 0.157 0.006 DBMET02906 0.158 0.006 DBMET02907 0.142 0.009 DBMET02902 0.103 0.03 DBMET02903 | DBMET02905 | |
| 0.163 | 0.015 | 0.208 | Toll-Like receptor 4 antagonist | 0.156 0.018 DBMET00372 0.138 0.029 DBMET02900 0.138 0.029 DBMET02901 0.159 0.017 DB14681 0.194 0.007 DBMET02905 0.173 0.011 DBMET02904 0.194 0.007 DBMET02906 0.17 0.012 DBMET02907 0.146 0.023 DBMET02902 0.208 0.005 DBMET02903 | DBMET02903 | |
| 0.193 | 0.045 | 0.193 | Acetylcholine M1 receptor antagonist | 0.137 0.088 DBMET00372 0.139 0.086 DBMET02900 0.139 0.086 DBMET02901 | ||
| 0.15 | 0.005 | 0.165 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.08 0.016 DBMET00372 0.068 0.023 DBMET02900 0.068 0.023 DBMET02901 0.165 0.004 DB14681 0.07 0.021 DBMET02902 0.131 0.006 DBMET02903 | DB14681 | |
| 0.145 | 0.004 | 0.153 | Estrone sulfatase inhibitor | 0.128 0.004 DBMET00372 0.139 0.004 DBMET02900 0.139 0.004 DBMET02901 0.153 0.003 DB14681 0.033 0.01 DBMET02905 0.045 0.008 DBMET02904 0.034 0.01 DBMET02906 0.038 0.009 DBMET02907 0.125 0.004 DBMET02902 0.138 0.004 DBMET02903 | DB14681 | |
| 0.188 | 0.049 | 0.365 | Amylase inhibitor | 0.126 0.078 DB14681 0.248 0.029 DBMET02905 0.365 0.012 DBMET02904 0.25 0.028 DBMET02906 0.238 0.032 DBMET02907 0.101 0.096 DBMET02902 0.121 0.081 DBMET02903 | DBMET02904 | |
| 0.161 | 0.022 | 0.167 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 DBMET00372 0.167 0.015 DBMET02900 0.167 0.015 DBMET02901 0.154 0.034 DB14681 0.153 0.035 DBMET02905 0.158 0.027 DBMET02904 0.153 0.036 DBMET02906 0.164 0.019 DBMET02907 0.167 0.015 DBMET02902 0.136 0.091 DBMET02903 | DBMET02902 | |
| 0.163 | 0.024 | 0.218 | Antineoplastic alkaloid | 0.159 0.025 DBMET00372 0.218 0.009 DBMET02900 0.218 0.009 DBMET02901 0.098 0.049 DB14681 0.101 0.047 DBMET02905 0.075 0.072 DBMET02906 0.164 0.024 DBMET02902 0.09 0.055 DBMET02903 | DBMET02901 | |
| 0.143 | 0.008 | 0.173 | Glycine receptor agonist | 0.093 0.026 DBMET00372 0.096 0.023 DBMET02900 0.096 0.023 DBMET02901 0.118 0.013 DB14681 0.109 0.016 DBMET02905 0.173 0.005 DBMET02904 0.097 0.022 DBMET02906 0.101 0.02 DBMET02907 0.139 0.008 DBMET02902 0.098 0.022 DBMET02903 | DBMET02904 | |
| 0.134 | 0.004 | 0.157 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.078 0.005 DBMET00372 0.082 0.005 DBMET02900 0.082 0.005 DBMET02901 0.157 0.003 DB14681 0.143 0.004 DBMET02902 0.127 0.004 DBMET02903 | DB14681 | |
| 0.221 | 0.102 | 0.44 | Interleukin agonist | 0.185 0.134 DBMET02900 0.185 0.134 DBMET02901 0.187 0.133 DB14681 0.428 0.015 DBMET02905 0.324 0.038 DBMET02904 0.44 0.014 DBMET02906 0.404 0.018 DBMET02907 0.277 0.061 DBMET02902 0.254 0.076 DBMET02903 | DBMET02906 | |
| 0.161 | 0.046 | 0.182 | Adenylate cyclase stimulant | 0.156 0.053 DBMET00372 0.166 0.04 DBMET02900 0.166 0.04 DBMET02901 0.124 0.115 DB14681 0.125 0.114 DBMET02905 0.128 0.106 DBMET02904 0.131 0.1 DBMET02907 0.182 0.024 DBMET02902 0.15 0.063 DBMET02903 | DBMET02902 | |
| 0.116 | 0.004 | 0.116 | Nitric oxide donor | 0.112 0.005 DBMET00372 0.115 0.004 DBMET02900 0.115 0.004 DBMET02901 0.109 0.005 DB14681 0.112 0.005 DBMET02905 0.113 0.005 DBMET02904 0.106 0.006 DBMET02906 0.108 0.005 DBMET02907 0.111 0.005 DBMET02902 0.072 0.031 DBMET02903 | ||
| 0.168 | 0.056 | 0.344 | Protein kinase stimulant | 0.155 0.065 DBMET00372 0.145 0.072 DBMET02900 0.145 0.072 DBMET02901 0.176 0.052 DB14681 0.185 0.047 DBMET02905 0.162 0.06 DBMET02904 0.257 0.025 DBMET02906 0.344 0.012 DBMET02907 0.266 0.023 DBMET02902 0.167 0.057 DBMET02903 | DBMET02907 | |
| 0.125 | 0.016 | 0.133 | Bile acid receptor antagonist | 0.113 0.026 DBMET00372 0.124 0.017 DBMET02900 0.124 0.017 DBMET02901 0.103 0.042 DB14681 0.106 0.037 DBMET02905 0.088 0.08 DBMET02906 0.133 0.012 DBMET02902 0.098 0.054 DBMET02903 | DBMET02902 | |
| 0.171 | 0.071 | 0.548 | Phospholipase C inhibitor | 0.179 0.062 DBMET00372 0.244 0.026 DBMET02900 0.244 0.026 DBMET02901 0.176 0.065 DB14681 0.232 0.029 DBMET02905 0.332 0.015 DBMET02906 0.266 0.022 DBMET02907 0.548 0.005 DBMET02902 0.156 0.094 DBMET02903 | DBMET02902 | |
| 0.147 | 0.049 | 0.153 | Aldehyde dehydrogenase inhibitor | 0.153 0.046 DB14681 | DB14681 | |
| 0.153 | 0.056 | 0.153 | Bone formation stimulant | 0.109 0.096 DBMET00372 0.142 0.065 DBMET02900 0.142 0.065 DBMET02901 0.127 0.079 DB14681 0.114 0.092 DBMET02905 0.147 0.062 DBMET02904 0.107 0.098 DBMET02902 0.119 0.087 DBMET02903 | ||
| 0.134 | 0.048 | 0.248 | Topoisomerase I inhibitor | 0.108 0.064 DBMET00372 0.115 0.059 DBMET02900 0.115 0.059 DBMET02901 0.118 0.057 DB14681 0.206 0.025 DBMET02905 0.218 0.022 DBMET02904 0.211 0.024 DBMET02906 0.248 0.017 DBMET02907 0.133 0.049 DBMET02902 | DBMET02907 | |
| 0.087 | 0.005 | 0.094 | Pregnane X receptor antagonist | 0.074 0.011 DBMET00372 0.065 0.02 DBMET02900 0.065 0.02 DBMET02901 0.089 0.004 DB14681 0.062 0.027 DBMET02902 0.094 0.004 DBMET02903 | DBMET02903 | |
| 0.144 | 0.065 | 0.178 | Neurotrophic factor | 0.159 0.052 DBMET00372 0.162 0.05 DBMET02900 0.162 0.05 DBMET02901 0.178 0.039 DBMET02905 0.136 0.073 DBMET02904 0.133 0.077 DBMET02906 0.12 0.095 DBMET02907 0.149 0.059 DBMET02902 | DBMET02905 | |
| 0.125 | 0.047 | 0.456 | Expectorant | 0.126 0.047 DBMET00372 0.185 0.024 DBMET02900 0.185 0.024 DBMET02901 0.403 0.005 DBMET02905 0.456 0.004 DBMET02904 0.288 0.009 DBMET02906 0.45 0.004 DBMET02907 0.218 0.017 DBMET02902 | DBMET02904 | |
| 0.105 | 0.034 | 0.239 | Transcription factor NF kappa B stimulant | 0.108 0.032 DBMET00372 0.121 0.024 DBMET02900 0.121 0.024 DBMET02901 0.138 0.019 DB14681 0.188 0.01 DBMET02905 0.162 0.014 DBMET02904 0.232 0.007 DBMET02906 0.239 0.006 DBMET02907 0.188 0.01 DBMET02902 0.168 0.013 DBMET02903 | DBMET02907 | |
| 0.082 | 0.015 | 0.197 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.073 0.018 DBMET00372 0.154 0.005 DBMET02900 0.154 0.005 DBMET02901 0.124 0.008 DB14681 0.051 0.028 DBMET02905 0.071 0.018 DBMET02906 0.063 0.022 DBMET02907 0.197 0.005 DBMET02902 0.075 0.017 DBMET02903 | DBMET02902 | |
| 0.107 | 0.042 | 0.107 | ABCA1 expression enhancer | 0.101 0.049 DB14681 0.094 0.058 DBMET02902 0.097 0.054 DBMET02903 | ||
| 0.119 | 0.055 | 0.2 | Mucolytic | 0.122 0.053 DBMET00372 0.161 0.027 DBMET02900 0.161 0.027 DBMET02901 0.161 0.026 DBMET02905 0.171 0.022 DBMET02904 0.136 0.041 DBMET02906 0.191 0.015 DBMET02907 0.2 0.013 DBMET02902 | DBMET02902 | |
| 0.079 | 0.016 | 0.152 | Heme oxygenase stimulant | 0.074 0.02 DBMET00372 0.074 0.021 DBMET02900 0.074 0.021 DBMET02901 0.152 0.003 DB14681 0.06 0.046 DBMET02905 0.061 0.043 DBMET02904 0.116 0.005 DBMET02906 0.114 0.005 DBMET02907 0.144 0.003 DBMET02902 0.143 0.003 DBMET02903 | DB14681 | |
| 0.093 | 0.033 | 0.106 | T cell inhibitor | 0.083 0.056 DBMET00372 0.106 0.02 DBMET02900 0.106 0.02 DBMET02901 0.084 0.052 DB14681 0.084 0.053 DBMET02904 0.089 0.039 DBMET02907 0.094 0.031 DBMET02902 | DBMET02901 | |
| 0.09 | 0.038 | 0.09 | Keratolytic | 0.083 0.045 DBMET00372 0.076 0.054 DBMET02900 0.076 0.054 DBMET02901 0.089 0.039 DB14681 0.088 0.04 DBMET02902 0.086 0.041 DBMET02903 | ||
| 0.143 | 0.093 | 0.143 | Growth hormone agonist | 0.121 0.12 DBMET00372 0.138 0.098 DBMET02900 0.138 0.098 DBMET02901 | ||
| 0.066 | 0.016 | 0.066 | Adenosine deaminase inhibitor | 0.049 0.032 DBMET00372 0.042 0.038 DBMET02900 0.042 0.038 DBMET02901 | ||
| 0.042 | 0.004 | 0.057 | Hedgehog signaling activator | 0.039 0.005 DBMET00372 0.042 0.004 DBMET02900 0.042 0.004 DBMET02901 0.031 0.011 DB14681 0.026 0.022 DBMET02905 0.057 0.003 DBMET02902 0.03 0.013 DBMET02903 | DBMET02902 | |
| 0.091 | 0.054 | 0.103 | Ornithine decarboxylase inhibitor | 0.075 0.073 DBMET00372 0.089 0.057 DBMET02900 0.089 0.057 DBMET02901 0.093 0.052 DB14681 0.103 0.041 DBMET02903 | DBMET02903 | |
| 0.056 | 0.02 | 0.061 | Microtubule stabilization | 0.055 0.022 DBMET00372 0.059 0.016 DBMET02900 0.059 0.016 DBMET02901 0.061 0.014 DBMET02905 0.057 0.018 DBMET02904 0.056 0.019 DBMET02906 0.054 0.023 DBMET02907 0.051 0.026 DBMET02902 | DBMET02905 | |
| 0.049 | 0.015 | 0.087 | Farnesoid X receptor agonist | 0.052 0.014 DBMET00372 0.087 0.005 DBMET02900 0.087 0.005 DBMET02901 0.042 0.021 DBMET02905 0.079 0.005 DBMET02902 | DBMET02901 | |
| 0.149 | 0.116 | 0.334 | Non-steroidal antiinflammatory agent | 0.205 0.067 DBMET02900 0.205 0.067 DBMET02901 0.334 0.022 DBMET02905 0.222 0.056 DBMET02904 0.213 0.061 DBMET02906 0.226 0.054 DBMET02907 | DBMET02905 | |
| 0.173 | 0.141 | 0.373 | Peptidyltransferase inhibitor | 0.165 0.157 DBMET00372 0.181 0.127 DBMET02900 0.181 0.127 DBMET02901 0.328 0.016 DBMET02905 0.361 0.01 DBMET02904 0.328 0.016 DBMET02906 0.373 0.009 DBMET02907 0.23 0.067 DBMET02902 0.203 0.096 DBMET02903 | DBMET02907 | |
| 0.158 | 0.129 | 0.442 | Hypolipemic | 0.199 0.095 DBMET00372 0.194 0.099 DBMET02900 0.194 0.099 DBMET02901 0.157 0.13 DB14681 0.432 0.02 DBMET02905 0.308 0.046 DBMET02904 0.442 0.018 DBMET02906 0.367 0.031 DBMET02907 0.366 0.032 DBMET02902 0.243 0.07 DBMET02903 | DBMET02906 | |
| 0.108 | 0.081 | 0.108 | Acetylcholine muscarinic antagonist | 0.098 0.094 DBMET02900 0.098 0.094 DBMET02901 | ||
| 0.083 | 0.057 | 0.085 | Estrogen-related receptor beta agonist | 0.085 0.053 DB14681 0.083 0.057 DBMET02902 0.078 0.074 DBMET02903 | DB14681 | |
| 0.155 | 0.13 | 0.239 | Growth factor agonist | 0.239 0.036 DBMET02900 0.239 0.036 DBMET02901 0.159 0.123 DBMET02905 0.152 0.138 DBMET02902 | DBMET02901 | |
| 0.159 | 0.135 | 0.432 | Free radical scavenger | 0.432 0.024 DBMET02905 0.374 0.034 DBMET02904 0.4 0.029 DBMET02906 0.358 0.037 DBMET02907 | DBMET02905 | |
| 0.107 | 0.086 | 0.115 | Cholinergic antagonist | 0.115 0.078 DBMET02900 0.115 0.078 DBMET02901 0.102 0.093 DBMET02902 | DBMET02901 | |
| 0.026 | 0.006 | 0.028 | Progesterone receptor B antagonist | 0.023 0.009 DBMET00372 0.02 0.013 DBMET02900 0.02 0.013 DBMET02901 0.028 0.005 DB14681 0.018 0.016 DBMET02902 0.025 0.007 DBMET02903 | DB14681 | |
| 0.023 | 0.005 | 0.037 | Telomerase stimulant | 0.025 0.004 DBMET00372 0.025 0.004 DBMET02900 0.025 0.004 DBMET02901 0.032 0.003 DBMET02905 0.037 0.002 DBMET02904 0.024 0.005 DBMET02906 0.029 0.003 DBMET02907 0.021 0.006 DBMET02902 | DBMET02904 | |
| 0.104 | 0.087 | 0.111 | Acetylcholine antagonist | 0.111 0.078 DBMET02900 0.111 0.078 DBMET02901 0.099 0.094 DBMET02902 | DBMET02901 | |
| 0.095 | 0.078 | 0.173 | Beta glucuronidase inhibitor | 0.167 0.019 DBMET02905 0.173 0.017 DBMET02904 0.122 0.044 DBMET02906 0.11 0.057 DBMET02907 | DBMET02904 | |
| 0.019 | 0.003 | 0.02 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.018 0.003 DBMET00372 0.015 0.004 DBMET02900 0.015 0.004 DBMET02901 0.02 0.003 DB14681 0.013 0.007 DBMET02902 0.019 0.003 DBMET02903 | DB14681 | |
| 0.024 | 0.011 | 0.027 | Vitamin D receptor antagonist | 0.023 0.013 DBMET00372 0.024 0.011 DBMET02900 0.024 0.011 DBMET02901 0.021 0.016 DB14681 0.025 0.01 DBMET02905 0.021 0.017 DBMET02904 0.024 0.012 DBMET02906 0.021 0.018 DBMET02907 0.027 0.008 DBMET02902 0.023 0.014 DBMET02903 | DBMET02902 | |
| 0.079 | 0.066 | 0.269 | GABA A receptor agonist | 0.154 0.015 DBMET02900 0.154 0.015 DBMET02901 0.118 0.025 DB14681 0.269 0.005 DBMET02902 | DBMET02902 | |
| 0.016 | 0.004 | 0.023 | Progesterone receptor A antagonist | 0.023 0.003 DB14681 0.016 0.004 DBMET02903 | DB14681 | |
| 0.055 | 0.045 | 0.15 | HIV-1 integrase (Strand Transfer) inhibitor | 0.15 0.013 DBMET00372 0.059 0.042 DBMET02904 | DBMET00372 | |
| 0.018 | 0.009 | 0.063 | Vitamin D receptor agonist | 0.018 0.008 DBMET00372 0.043 0.003 DBMET02900 0.043 0.003 DBMET02901 0.018 0.009 DB14681 0.032 0.004 DBMET02905 0.037 0.003 DBMET02906 0.026 0.004 DBMET02907 0.063 0.002 DBMET02902 0.021 0.006 DBMET02903 | DBMET02902 | |
| 0.042 | 0.033 | 0.042 | Liver X receptor agonist | |||
| 0.039 | 0.031 | 0.039 | Liver X receptor alpha agonist | |||
| 0.193 | 0.187 | 0.6 | Antithrombotic | 0.195 0.183 DBMET02900 0.195 0.183 DBMET02901 0.6 0.016 DBMET02905 0.584 0.018 DBMET02904 0.441 0.04 DBMET02906 0.463 0.035 DBMET02907 | DBMET02905 | |
| 0.091 | 0.089 | 0.328 | GABA receptor agonist | 0.192 0.02 DBMET02900 0.192 0.02 DBMET02901 0.171 0.026 DB14681 0.328 0.005 DBMET02902 | DBMET02902 | |
| 0.02 | 0.018 | 0.02 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.066 | 0.064 | 0.1 | CDC25A inhibitor | 0.068 0.06 DBMET00372 0.088 0.035 DBMET02900 0.088 0.035 DBMET02901 0.068 0.06 DBMET02905 0.068 0.06 DBMET02906 0.066 0.065 DBMET02907 0.1 0.027 DBMET02902 | DBMET02902 | |
| 0.187 | 0.185 | 0.288 | Angiogenesis inhibitor | 0.288 0.099 DBMET02905 0.26 0.116 DBMET02904 0.276 0.106 DBMET02906 0.255 0.119 DBMET02907 | DBMET02905 | |
| 0.034 | 0.037 | 0.056 | GABA uptake inhibitor | 0.056 0.012 DBMET02900 0.056 0.012 DBMET02901 0.049 0.017 DB14681 0.056 0.012 DBMET02902 | DBMET02902 | |
| 0.031 | 0.036 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.032 0.031 DBMET02900 0.032 0.031 DBMET02901 0.039 0.018 DBMET02905 0.042 0.014 DBMET02902 | DBMET02902 | |
| 0.019 | 0.025 | 0.058 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET02900 0.023 0.018 DBMET02901 0.05 0.008 DBMET02905 0.058 0.006 DBMET02904 0.036 0.011 DBMET02906 0.057 0.007 DBMET02907 | DBMET02904 | |
| 0.087 | 0.093 | 0.093 | Hedgehog signaling inhibitor | 0.093 0.079 DB14681 | DB14681 | |
| 0.016 | 0.022 | 0.03 | Antibiotic Anthracycline-like | 0.018 0.017 DBMET00372 0.018 0.015 DBMET02900 0.018 0.015 DBMET02901 0.029 0.004 DBMET02905 0.024 0.005 DBMET02904 0.03 0.004 DBMET02906 0.029 0.004 DBMET02907 0.019 0.014 DBMET02902 | DBMET02906 | |
| 0.036 | 0.049 | 0.059 | Potassium channel Kv1.3 blocker | 0.059 0.022 DBMET02900 0.059 0.022 DBMET02901 0.056 0.023 DBMET02902 | DBMET02901 | |
| 0.028 | 0.042 | 0.034 | Tubulin agonist | 0.032 0.028 DBMET02900 0.032 0.028 DBMET02901 0.034 0.025 DBMET02902 | DBMET02902 | |
| 0.124 | 0.139 | 0.432 | Platelet adhesion inhibitor | 0.431 0.009 DBMET02905 0.333 0.024 DBMET02904 0.432 0.009 DBMET02906 0.387 0.013 DBMET02907 0.191 0.076 DBMET02902 | DBMET02906 | |
| 0.038 | 0.06 | 0.053 | Parathyroid hormone antagonist | 0.053 0.017 DBMET02902 | DBMET02902 | |
| 0.025 | 0.049 | 0.04 | HMG CoA reductase inhibitor | 0.033 0.027 DBMET02905 0.035 0.023 DBMET02906 0.04 0.014 DBMET02902 | DBMET02902 | |
| 0.034 | 0.066 | 0.111 | Protein 50S ribosomal subunit inhibitor | 0.088 0.016 DBMET02905 0.105 0.012 DBMET02904 0.094 0.015 DBMET02906 0.111 0.011 DBMET02907 0.05 0.04 DBMET02902 | DBMET02907 | |
| 0.003 | 0.037 | 0.018 | Antibiotic Macrolide-like | 0.018 0.008 DBMET02904 0.014 0.01 DBMET02907 | DBMET02904 | |
| 0.117 | 0.152 | 0.137 | Tumour necrosis factor antagonist | 0.137 0.118 DB14681 | DB14681 | |
| 0.025 | 0.065 | 0.07 | Antibiotic Aminoglycoside-like | 0.058 0.009 DBMET02905 0.066 0.007 DBMET02904 0.057 0.01 DBMET02906 0.07 0.006 DBMET02907 | DBMET02907 | |
| 0.161 | 0.207 | 0.187 | Gastrin inhibitor | 0.187 0.168 DBMET02900 0.187 0.168 DBMET02901 | DBMET02901 | |
| 0.085 | 0.131 | 0.235 | Cyclooxygenase 3 inhibitor | 0.156 0.044 DBMET02905 0.194 0.021 DBMET02904 0.156 0.043 DBMET02906 0.235 0.01 DBMET02907 | DBMET02907 | |
| 0.036 | 0.083 | 0.081 | Alpha-mannosidase inhibitor | 0.081 0.011 DBMET02905 0.07 0.017 DBMET02904 0.066 0.02 DBMET02906 0.068 0.018 DBMET02907 | DBMET02905 | |
| 0.064 | 0.114 | 0.104 | Prolactin inhibitor | 0.087 0.071 DBMET02900 0.087 0.071 DBMET02901 0.083 0.076 DB14681 0.104 0.052 DBMET02902 | DBMET02902 | |
| 0.149 | 0.202 | 0.186 | RNA-directed DNA polymerase inhibitor | 0.186 0.122 DBMET02900 0.186 0.122 DBMET02901 0.168 0.157 DBMET02902 | DBMET02901 | |
| 0.005 | 0.061 | 0.043 | Ileal bile acid transport inhibitor | 0.043 0.004 DBMET02905 0.027 0.005 DBMET02906 0.026 0.006 DBMET02907 0.026 0.006 DBMET02902 | DBMET02905 | |
| 0.039 | 0.096 | 0.106 | HIV-1 integrase (3'-Processing) inhibitor | 0.106 0.024 DBMET00372 | DBMET00372 | |
| 0.069 | 0.127 | 0.108 | Nitric-oxide synthase inhibitor | 0.108 0.048 DB14681 | DB14681 | |
| 0.063 | 0.129 | 0.093 | UDP-glucose 4-epimerase inhibitor | 0.087 0.077 DBMET02906 0.093 0.07 DBMET02907 | DBMET02907 | |
| 0.03 | 0.097 | 0.375 | GABA receptor antagonist | 0.071 0.025 DBMET02900 0.071 0.025 DBMET02901 0.129 0.011 DB14681 0.375 0.004 DBMET02902 | DBMET02902 | |
| 0.136 | 0.206 | 0.551 | Hypoglycemic | 0.551 0.011 DBMET02905 0.448 0.021 DBMET02904 0.496 0.015 DBMET02906 0.468 0.018 DBMET02907 | DBMET02905 | |
| 0.121 | 0.198 | 0.416 | Spasmolytic | 0.182 0.135 DBMET02900 0.182 0.135 DBMET02901 0.159 0.155 DB14681 0.193 0.126 DBMET02905 0.282 0.077 DBMET02906 0.416 0.037 DBMET02907 0.29 0.074 DBMET02902 0.181 0.136 DBMET02903 | DBMET02907 | |
| 0.059 | 0.137 | 0.179 | Protein-tyrosine phosphatase 1B inhibitor | 0.16 0.042 DBMET02905 0.093 0.086 DBMET02904 0.179 0.035 DBMET02906 0.131 0.055 DBMET02907 0.115 0.067 DBMET02902 | DBMET02906 | |
| 0.077 | 0.163 | 0.239 | Thrombolytic | 0.218 0.044 DBMET02905 0.239 0.036 DBMET02904 0.182 0.061 DBMET02906 0.226 0.041 DBMET02907 | DBMET02904 | |
| 0.02 | 0.112 | 0.065 | Mannosidase inhibitor | 0.065 0.014 DBMET02905 0.054 0.021 DBMET02904 0.049 0.027 DBMET02906 0.051 0.024 DBMET02907 | DBMET02905 | |
| 0.028 | 0.13 | 0.081 | Phosphofructokinase-1 inhibitor | 0.081 0.04 DBMET02907 | DBMET02907 | |
| 0.022 | 0.156 | 0.332 | GABA A receptor antagonist | 0.109 0.014 DB14681 0.332 0.004 DBMET02902 | DBMET02902 | |
| 0.014 | 0.152 | 0.087 | Phosphorylase inhibitor | 0.087 0.015 DBMET02905 | DBMET02905 | |
| 0.136 | 0.296 | 0.399 | Antiobesity | 0.302 0.114 DBMET02905 0.364 0.081 DBMET02906 0.399 0.066 DBMET02907 0.376 0.075 DBMET02902 0.24 0.166 DBMET02903 | DBMET02907 | |
| 0.076 | 0.267 | 0.21 | Insulin secretagoues | 0.21 0.031 DBMET02905 0.179 0.049 DBMET02904 0.158 0.066 DBMET02906 0.166 0.059 DBMET02907 | DBMET02905 | |
| 0.023 | 0.218 | 0.056 | Glucose-6-phosphate translocase inhibitor | 0.054 0.031 DBMET02905 0.056 0.029 DBMET02904 0.05 0.039 DBMET02906 0.054 0.031 DBMET02907 | DBMET02904 | |
| 0.046 | 0.253 | 0.128 | Beta amyloid protein antagonist | 0.128 0.06 DBMET02905 | DBMET02905 | |
| 0.061 | 0.273 | 0.216 | Cell wall synthesis inhibitor | 0.124 0.093 DBMET02905 0.216 0.024 DBMET02904 0.123 0.096 DBMET02906 0.204 0.028 DBMET02907 | DBMET02904 | |
| 0.08 | 0.297 | 0.284 | Vasodilator | 0.257 0.065 DBMET02905 0.188 0.115 DBMET02904 0.259 0.064 DBMET02906 0.284 0.054 DBMET02907 | DBMET02907 | |
| 0.02 | 0.243 | 0.063 | Neuraminidase (influenza) inhibitor | 0.063 0.046 DBMET02904 | DBMET02904 | |
| 0.014 | 0.239 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET02905 0.026 0.019 DBMET02904 0.029 0.013 DBMET02906 0.026 0.019 DBMET02907 | DBMET02905 | |
| 0.021 | 0.246 | 0.067 | Acetyl-CoA transferase 2 inhibitor | 0.067 0.021 DBMET02902 | DBMET02902 | |
| 0.046 | 0.278 | 0.154 | Protein-tyrosine phosphatase inhibitor | 0.137 0.093 DBMET02905 0.154 0.074 DBMET02906 | DBMET02906 | |
| 0.043 | 0.279 | 0.093 | Lanosterol 14 alpha demethylase inhibitor | 0.093 0.067 DBMET02902 | DBMET02902 | |
| 0.017 | 0.27 | 0.063 | GABA B receptor antagonist | 0.063 0.011 DBMET02902 | DBMET02902 | |
| 0.066 | 0.328 | 0.119 | DNA repair enzyme inhibitor | 0.119 0.073 DBMET02904 0.111 0.092 DBMET02907 | DBMET02904 | |
| 0.093 | 0.367 | 0.135 | CC chemokine 6 receptor antagonist | 0.132 0.062 DBMET02905 0.133 0.061 DBMET02904 0.13 0.071 DBMET02906 0.135 0.052 DBMET02907 | DBMET02907 | |
| 0.07 | 0.354 | 0.185 | Cardiotonic | 0.185 0.134 DBMET02902 | DBMET02902 | |
| 0.012 | 0.306 | 0.304 | Selectin antagonist | 0.304 0.005 DBMET02905 0.248 0.008 DBMET02904 0.292 0.006 DBMET02906 0.271 0.007 DBMET02907 | DBMET02905 | |
| 0.027 | 0.347 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.044 DBMET02905 0.052 0.049 DBMET02906 | DBMET02905 | |
| 0.039 | 0.381 | 0.185 | Cell adhesion inhibitor | 0.185 0.029 DBMET02905 0.105 0.08 DBMET02904 0.129 0.059 DBMET02906 0.099 0.091 DBMET02907 | DBMET02905 | |
| 0.125 | 0.487 | 0.332 | Calcium channel L-type activator | 0.332 0.131 DBMET02903 | DBMET02903 | |
| 0.026 | 0.419 | 0.084 | GABA B receptor agonist | 0.084 0.034 DBMET02902 | DBMET02902 | |
| 0.04 | 0.458 | 0.159 | Hemostatic | 0.136 0.086 DBMET02905 0.129 0.097 DBMET02904 0.159 0.057 DBMET02907 | DBMET02907 | |
| 0.014 | 0.468 | 0.097 | Heparanase inhibitor | 0.096 0.004 DBMET02905 0.056 0.031 DBMET02904 0.09 0.005 DBMET02906 0.097 0.004 DBMET02907 | DBMET02907 | |
| 0.025 | 0.532 | 0.206 | Platelet antagonist | 0.206 0.097 DBMET02905 0.148 0.147 DBMET02904 0.149 0.146 DBMET02906 | DBMET02905 | |
| 0.034 | 0.546 | 0.087 | Ca(v)3.1 blocker | 0.087 0.042 DB14681 0.079 0.064 DBMET02903 | DB14681 | |
| 0.05 | 0.584 | 0.217 | Vasodilator, coronary | 0.212 0.171 DBMET02905 0.217 0.166 DBMET02906 | DBMET02906 | |
| 0.028 | 0.62 | 0.23 | ATPase inhibitor | 0.16 0.084 DBMET02906 0.23 0.019 DBMET02907 | DBMET02907 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |